Q1 2021 Holdings
Filed 2021-05-17 | 71 holdings | $104.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $61.7M | 2,195,892 | 59.1% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $21.1M | 318,704 | 20.2% |
| Alector Inc(ALEC) | COM | 014442107 | $12.1M | 602,600 | 11.6% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $7.4M | 200,000 | 7.1% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $277.2K | 11,034,280 | 0.3% |
| Xencor Inc(XNCR) | COM | 98401F105 | $211.0K | 4,900,306 | 0.2% |
| Morphic Hldg Inc | COM | 61775R105 | $189.8K | 2,999,315 | 0.2% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $154.1K | 7,151,624 | 0.1% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $138.4K | 13,247,017 | 0.1% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $118.6K | 3,429,363 | 0.1% |
| Silverback Therapeutics Inc(SPRY) | COM | 82835W108 | $110.5K | 2,533,635 | 0.1% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $104.4K | 3,692,637 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $79.5K | 464,298 | 0.1% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $75.8K | 3,092,218 | 0.1% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $71.9K | 2,458,259 | 0.1% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $62.8K | 2,019,019 | 0.1% |
| Solid Biosciences Inc | COM | 83422E105 | $50.9K | 9,202,702 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $45.9K | 2,103,950 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $39.8K | 1,224,175 | 0.0% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $38.4K | 3,122,704 | 0.0% |
| Atreca Inc(BCELUSD) | CL A COM | 04965G109 | $37.2K | 2,426,685 | 0.0% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $34.0K | 1,137,940 | 0.0% |
| Gritstone Oncology Inc(2JQ) | COM | 39868T105 | $32.3K | 3,421,287 | 0.0% |
| AC Immune SA(ACIU) | SHS | H00263105 | $27.8K | 3,648,163 | 0.0% |
| Akouos Inc | COM | 00973J101 | $27.4K | 1,975,984 | 0.0% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $24.5K | 6,082,200 | 0.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $19.4K | 1,250,001 | 0.0% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $11.9K | 1,115,721 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $11.3K | 387,357 | 0.0% |
| Applied Molecular Trans Inc | COM | 03824M109 | $10.5K | 239,443 | 0.0% |
| Allovir Inc | COM | 019818103 | $10.5K | 447,012 | 0.0% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $10.1K | 963,333 | 0.0% |
| Translate BIO Inc | COM | 89374L104 | $9.8K | 596,900 | 0.0% |
| Bctg Acquisition Corp | COM | 05492W103 | $8.9K | 800,000 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $8.9K | 260,000 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $7.9K | 741,290 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $7.5K | 1,000,000 | 0.0% |
| Magenta Therapeutics Inc | COM | 55910K108 | $6.6K | 556,354 | 0.0% |
| Prothena Corp PLC(PRTA)Call | SHS | G72800108 | $6.3K | 250,000 | 0.0% |
| Logicbio Therapeutics Inc | COM | 54142F102 | $5.0K | 688,700 | 0.0% |
| Bolt Biotherapeutics Inc(BOLT1EUR) | COM | 097702104 | $4.9K | 150,000 | 0.0% |
| Jiya Acquisition Corp | COM CL A | 47760M102 | $4.9K | 500,000 | 0.0% |
| Cyclerion Therapeutics Inc(CYCNUSD) | COM | 23255M105 | $4.5K | 1,606,276 | 0.0% |
| Health Sciences ACQ Corp 2 | ORD SHS | G4411D109 | $4.5K | 400,000 | 0.0% |
| NGM Biopharmaceuticals Inc(NGMUSD) | COM | 62921N105 | $4.2K | 143,567 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $3.9K | 100,000 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $3.3K | 215,000 | 0.0% |
| Vincerx Pharma Inc | *W EXP 12/24/202 | 92731L114 | $2.9K | 150,000 | 0.0% |
| Aerpio Pharmaceuticals Inc | COM | 00810B105 | $2.7K | 2,072,782 | 0.0% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $2.5K | 50,000 | 0.0% |